Investor profile
Oxford Science Enterprises has backed 29 European tech companies across 34 funding rounds between 2022 and 2026, joining rounds totalling €1.2B. Most active in Healthtech and Cleantech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Oxford Quantum Circuits | UK | 2 | €346M |
| Quantum Motion | UK | 1 | €136M |
| OMass Therapeutics | UK | 1 | €90M |
| Grey Wolf Therapeutics | UK | 2 | €87M |
| Osler Diagnostics | UK |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Oxford Quantum Circuits | Series C | €301M | 2026-06 |
| Quantum Motion | Series C | €136M | 2026-05 |
| OMass Therapeutics | Series B | €90M | 2022-04 |
| Osler Diagnostics |
| 1 |
| €85M |
| moa Technology Limited | UK | 2 | €67M |
| PQShield | UK | 2 | €52M |
| Ultromics | UK | 1 | €48M |
| First Light Fusion | UK | 1 | €40M |
| Nucleome Therapeutics | UK | 1 | €38M |
| Oxford Ionics | UK | 1 | €34M |
| Fractile | UK | 2 | €33M |
| Scenic Biotech | Netherlands | 1 | €28M |
| Mixergy | UK | 1 | €14M |
| ORCA Computing | UK | 1 | €14M |
| Vivid Dx | UK | 1 | €13M |
| Salience Labs | UK | 1 | €11M |
| Brill Power | UK | 1 | €10M |
| FluoRok | UK | 1 | €9.2M |
| Natcap | UK | 1 | €9.2M |
| Util | UK | 1 | €6.1M |
| Navenio | UK | 1 | €5.9M |
| NavLive | UK | 1 | €4.8M |
| Mirae | UK | 1 | €4.7M |
| Archangel Lightworks | UK | 1 | €4.5M |
| Stateful Robotics | UK | 1 | €4.1M |
| Opsydia | UK | 1 | €4.0M |
| Porpoise Power | UK | 1 | €1.4M |
| iotaSciences | UK | 1 | €0 |
| Series C |
| €85M |
| 2022-11 |
| Ultromics | Series C | €48M | 2025-07 |
| Oxford Quantum Circuits | Series A | €45M | 2022-07 |
| Grey Wolf Therapeutics | Series B | €45M | 2023-01 |
| Grey Wolf Therapeutics | Series B | €42M | 2024-05 |
| moa Technology Limited | Series B | €41M | 2022-06 |
| First Light Fusion | Series C | €40M | 2022-02 |
